EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ..
OBJECTIVE: To develop evidence-based recommendations for the non-pharmacological management of systemic lupus erythematosus (SLE) and systemic sclerosis (SSc).
METHODS: A task force comprising 7 rheumatologists, 15 other healthcare professionals and 3 patients was established. Following a systematic literature review performed to inform the recommendations, statements were formulated, discussed during online meetings and graded based on risk of bias assessment, level of evidence (LoE) and strength of recommendation (SoR; scale A-D, A comprising consistent LoE 1 studies, D comprising LoE 4 or inconsistent studies), following the European Alliance of Associations for Rheumatology standard operating procedure. Level of agreement (LoA; scale 0-10, 0 denoting complete disagreement, 10 denoting complete agreement) was determined for each statement through online voting.
RESULTS: Four overarching principles and 12 recommendations were developed. These concerned common and disease-specific aspects of non-pharmacological management. SoR ranged from A to D. The mean LoA with the overarching principles and recommendations ranged from 8.4 to 9.7. Briefly, non-pharmacological management of SLE and SSc should be tailored, person-centred and participatory. It is not intended to preclude but rather complement pharmacotherapy. Patients should be offered education and support for physical exercise, smoking cessation and avoidance of cold exposure. Photoprotection and psychosocial interventions are important for SLE patients, while mouth and hand exercises are important in SSc.
CONCLUSIONS: The recommendations will guide healthcare professionals and patients towards a holistic and personalised management of SLE and SSc. Research and educational agendas were developed to address needs towards a higher evidence level, enhancement of clinician-patient communication and improved outcomes.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2023 |
|---|---|
| Enthalten in: |
Annals of the rheumatic diseases - (2023) vom: 23. Aug. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Parodis, Ioannis [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Journal Article |
|---|
| Anmerkungen: |
Date Revised 20.12.2023 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1136/ard-2023-224416 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM359344313 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM359344313 | ||
| 003 | DE-627 | ||
| 005 | 20231227135232.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/ard-2023-224416 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1234.xml |
| 035 | |a (DE-627)NLM359344313 | ||
| 035 | |a (NLM)37433575 | ||
| 035 | |a (PII)ard-2023-224416 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Parodis, Ioannis |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 20.12.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a © Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. | ||
| 520 | |a OBJECTIVE: To develop evidence-based recommendations for the non-pharmacological management of systemic lupus erythematosus (SLE) and systemic sclerosis (SSc) | ||
| 520 | |a METHODS: A task force comprising 7 rheumatologists, 15 other healthcare professionals and 3 patients was established. Following a systematic literature review performed to inform the recommendations, statements were formulated, discussed during online meetings and graded based on risk of bias assessment, level of evidence (LoE) and strength of recommendation (SoR; scale A-D, A comprising consistent LoE 1 studies, D comprising LoE 4 or inconsistent studies), following the European Alliance of Associations for Rheumatology standard operating procedure. Level of agreement (LoA; scale 0-10, 0 denoting complete disagreement, 10 denoting complete agreement) was determined for each statement through online voting | ||
| 520 | |a RESULTS: Four overarching principles and 12 recommendations were developed. These concerned common and disease-specific aspects of non-pharmacological management. SoR ranged from A to D. The mean LoA with the overarching principles and recommendations ranged from 8.4 to 9.7. Briefly, non-pharmacological management of SLE and SSc should be tailored, person-centred and participatory. It is not intended to preclude but rather complement pharmacotherapy. Patients should be offered education and support for physical exercise, smoking cessation and avoidance of cold exposure. Photoprotection and psychosocial interventions are important for SLE patients, while mouth and hand exercises are important in SSc | ||
| 520 | |a CONCLUSIONS: The recommendations will guide healthcare professionals and patients towards a holistic and personalised management of SLE and SSc. Research and educational agendas were developed to address needs towards a higher evidence level, enhancement of clinician-patient communication and improved outcomes | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Patient Care Team | |
| 650 | 4 | |a Patient Reported Outcome Measures | |
| 650 | 4 | |a Patient perspective | |
| 650 | 4 | |a Systemic Lupus Erythematosus | |
| 650 | 4 | |a Systemic Sclerosis | |
| 700 | 1 | |a Girard-Guyonvarc'h, Charlotte |e verfasserin |4 aut | |
| 700 | 1 | |a Arnaud, Laurent |e verfasserin |4 aut | |
| 700 | 1 | |a Distler, Oliver |e verfasserin |4 aut | |
| 700 | 1 | |a Domján, Andrea |e verfasserin |4 aut | |
| 700 | 1 | |a Van den Ende, Cornelia H M |e verfasserin |4 aut | |
| 700 | 1 | |a Fligelstone, Kim |e verfasserin |4 aut | |
| 700 | 1 | |a Kocher, Agnes |e verfasserin |4 aut | |
| 700 | 1 | |a Larosa, Maddalena |e verfasserin |4 aut | |
| 700 | 1 | |a Lau, Martin |e verfasserin |4 aut | |
| 700 | 1 | |a Mitropoulos, Alexandros |e verfasserin |4 aut | |
| 700 | 1 | |a Ndosi, Mwidimi |e verfasserin |4 aut | |
| 700 | 1 | |a Poole, Janet L |e verfasserin |4 aut | |
| 700 | 1 | |a Redmond, Anthony |e verfasserin |4 aut | |
| 700 | 1 | |a Ritschl, Valentin |e verfasserin |4 aut | |
| 700 | 1 | |a Alexanderson, Helene |e verfasserin |4 aut | |
| 700 | 1 | |a Sjöberg, Yvonne |e verfasserin |4 aut | |
| 700 | 1 | |a von Perner, Gunilla |e verfasserin |4 aut | |
| 700 | 1 | |a Uhlig, Till |e verfasserin |4 aut | |
| 700 | 1 | |a Varju, Cecilia |e verfasserin |4 aut | |
| 700 | 1 | |a Vriezekolk, Johanna E |e verfasserin |4 aut | |
| 700 | 1 | |a Welin, Elisabet |e verfasserin |4 aut | |
| 700 | 1 | |a Westhovens, René |e verfasserin |4 aut | |
| 700 | 1 | |a Stamm, Tanja A |e verfasserin |4 aut | |
| 700 | 1 | |a Boström, Carina |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of the rheumatic diseases |d 1939 |g (2023) vom: 23. Aug. |w (DE-627)NLM000174114 |x 1468-2060 |7 nnns |
| 773 | 1 | 8 | |g year:2023 |g day:23 |g month:08 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1136/ard-2023-224416 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 23 |c 08 | ||